I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
First-line nivolumab plus ipilimumab in unresectable malign..:
Baas, Paul
;
Scherpereel, Arnaud
;
Nowak, Anna K
...
The Lancet. 397 (2021) 10272 - p. 375-386 , 2021
Link:
https://doi.org/10.1016/s0140-6736(20)32714-8
RT Journal T1
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial
UL https://suche.suub.uni-bremen.de/peid=cr-10.1016_s0140-6736(20)32714-8&Exemplar=1&LAN=DE A1 Baas, Paul A1 Scherpereel, Arnaud A1 Nowak, Anna K A1 Fujimoto, Nobukazu A1 Peters, Solange A1 Tsao, Anne S A1 Mansfield, Aaron S A1 Popat, Sanjay A1 Jahan, Thierry A1 Antonia, Scott A1 Oulkhouir, Youssef A1 Bautista, Yolanda A1 Cornelissen, Robin A1 Greillier, Laurent A1 Grossi, Francesco A1 Kowalski, Dariusz A1 Rodríguez-Cid, Jerónimo A1 Aanur, Praveen A1 Oukessou, Abderrahim A1 Baudelet, Christine A1 Zalcman, Gérard PB Elsevier BV YR 2021 SN 0140-6736 JF The Lancet VO 397 IS 10272 SP 375 OP 386 LK http://dx.doi.org/https://doi.org/10.1016/s0140-6736(20)32714-8 DO https://doi.org/10.1016/s0140-6736(20)32714-8 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)